A series of weak bases and the ionophore monensin were tested for their effect on the intracellular processing of type 1 poliovirus in HeLa cells. At concentrations that did not inhibit plaque formation or viral protein synthesis, the compounds suppressed the proteolytic processing of 135S particles and the formation of 110S particles. In addition, some compounds strongly reduced transit of modified particles to the lysosomes. These results suggest that transit to lysosomes and proteolysis of subviral particles are not essential steps in the infectious pathway. The role of 135S particles as intermediates in infection is discussed.
Introduction
Poliovirus infection of cultured cells has been reported to be moderately susceptible to agents known to perturb the intravesicular pH in endosomes and lysosomes (Madshus et al., 1984; Zeichhardt et al., 1985) , from which it was concluded that low pH was required for an as yet unidentified step in the productive pathway. Very recently, the opposite conclusion was drawn from the fact that poliovirus infection was not inhibited by the macrolide antibiotic bafilomycin A1, a relatively specific inhibitor of the vacuolar-type proton ATPase (P~rez & Carrasco, 1993) . Clearly, the requirement for low pH is less stringent for poliovirus than for Semliki Forest virus or vesicular stomatitis virus, both known to use the endosomal pathway for entry. Whether poliovirus uses this pathway, or penetrates directly from the plasma membrane is still a matter of debate, and it remains equally uncertain whether the genome penetrates this membrane as a virion or subviral particle, or enters the cell through a lipid bilayer.
Upon contact with the cell, intact 160S virions are quickly modified to more slowly sedimenting, intracellular 135S particles that still retain the viral RNA. The proteins of the intracellular 135S particles have been variously reported as being proteolytically cleaved, mainly in VP1 and VP2 (Lonberg-Holm et al., 1975; Everaert et al., 1989; Fricks & Hogle, 1990) , or as surviving in the uncleaved state (Wetz & Kucinski, 1991) . RNA-containing 110S subviral particles have also been described, which arise by proteolytic degradation of intracellular 135S particles in the lysosomes (Everaert et al., 1989 ; Kronenberger et at., 1992b) . Except for VP3, the proteins of the l l0S particles were extensively degraded. Intracellular 80S empty capsids are formed as well, and it has been hypothesized that they are formed in the cytosol as a result of productive uncoating (Kronenberger et al., 1992b) .
A substantial amount of input virus is eluted into the medium as so-called A-particles, which also sediment at about 135S. The proteins of A-particles, however, are uncleaved (Fricks & Hogle, 1990) .
The proteolytic processing of capsid proteins may be a necessary step in the productive pathway of at least some naked viruses. Reoviruses, for instance, require cleavages of the outer capsid, and probably infect the cell from within a lysosome (Sturzenbecker et al., 1987) .
The low pH which prevails in the endosomal/ lysosomal system is required for the proper functioning of acid proteases, and the addition of weak bases or protonophores should therefore inhibit proteolytic degradation of poliovirus subviral particles. According to the recent findings mentioned above (P6rez & Carrasco, 1993) , these manipulations should have no effect on infection.
Relatively high concentrations of weak bases and the protonophore monensin were reported to delay rather than inhibit permanently the generation of modified particles; however no correlation was made with proteolysis or infection (Gromeier & Wetz, 1990) .
We have previously shown that micromolar concentrations of chloroquine, a prototype weak base, redirected 135S production to 80S empty capsids in the lysosomes, without inhibition of infection (Kronenberger et al., 1991) . We now report the action of other weak bases, and of the protonophore monensin. The results show that proteolysis of 135S particles, generation of 110S particles, and even transit of modified particles to the lysosomes, can be inhibited without effect on infection.
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Methods
Virus. The procedures for poliovirus (type 1, strain Mahoney) labelling and purification, extraction of viral particles and sucrose gradient analysis were as described previously (Everaert et al., 1989) . The multiplicity of infection was 6000 virions/cell (about 30 p.fm./cell), except for the cellular fractionation experiments, in which the input was doubled. HeLa cell suspensions were lysed with 1% NP40 in PBS pH 8.0.
SDS-PAGE.
Polypeptide analysis by cylindrical or flatbed SDS-PAGE was performed as previously described (Everaert et al., 1989; Laemmli, 1970) . Cylindrical gels were cut into 1 mm slices, which were allowed to swell for 3 days in 400 lal Protosol (Du Pont, NEN). After addition of 4 ml ECONOFLUOR-2 scintillation cocktail (Du Pont, NEN), samples were left for 7 days and counted for 10 min each.
Gradient centrifugation. Cell homogenization and Nycodenz (Nycomed Pharma) gradient analysis were as described (Kronenberger et al., 1992a, b) . Briefly, cells were suspended in homogenization medium (8-5 % sucrose, 5 mM-Tris-HCl pH 8-0, 1 mM-EDTA), homogenized by mechanical shear using two connected 21-gauge l ml syringes. The post-nuclear supernatant was layered on 2% to 30% Nycodenz gradients, rendered isoosmotic by a counter-gradient of 8.5 % to 0 % sucrose and containing 5 mM-Tris HC1 pH 8-0, 1 mM-EDTA. Centrifugation was performed in an MSE 30.6 swing-out rotor for 1 h at 90000g. N-acetyl-fl-glucosaminidase was assayed as previously described (Kronenberger et al., 1992a) .
Chemicals. All compounds tested were purchased from Sigma, except hydroxychloroquine (Janssen); 10mM stock solutions were prepared in PBS pH 8.0 (chloroquine, neutral red, hydroxychloroquine), DMSO (amodiaquin, chlorpromazine) or 95% ethanol (monensin). Dilutions were made in Eagle's minimal essential medium (MEM). It was verified that none of the solvents by itself affected eclipse particle formation, and that addition of the compounds to the cell lysis mixture, even in 10-fold excess, did not alter the relative amounts of eclipse particles (data not shown).
Plaque assay. Plaque assay was performed using HeLa suspension cells, adapted to grow as a monolayer in Dulbecco's MEM. Infected monolayers were incubated for 30 rain at 37 °C, after which they were covered with an agar overlay. After 24 h the plates received a second overlay containing neutral red, and plaques were counted after another 12 h incubation at 37 °C.
Results
Effect of weak bases on the formation of eclipse particles
Chloroquine, a prototypic weak base, is known to favour the formation of 80S empty capsids over 135S particles during the eclipse phase (Kronenberger et al., 1991) . If 80S particle formation was a direct consequence of raising the intravesicular pH, then the effect was also expected with other weak bases, such as amodiaquin, a 4-amino-quinoline analogue of chloroquine. HeLa cells were preincubated for 15 minutes at 37 °C in MEM alone, or with 20 gu-chloroquine or 20 laM-amodiaquin. allow the accumulation of 110S particles (Everaert et al., 1989) . At 3 h post-infection (p.i.), part of the cell suspension was detergent-lysed and analysed by sucrose gradient ultracentrifugation.
As shown in Fig. 1 ,135S, 110S and 80S particles were formed in the control cells (Fig. 1 a) . With chloroquine only 80S particles were formed ( Fig. 1 b) , according to expectation. With amodiaquin, 135S and some 80S particles were formed, but no ll0S particles (Fig. 1 c) .
Thus, even though the effects of chloroquine and amodiaquin on the eclipse particles were different, both compounds inhibited the formation of 110S particles.
When other compounds that affect intravesicular pH were tested, it was realized that they formed two groups with different effects on the eclipse particles. The "chloroquine group', which included hydroxychloroquine (20 pM) and neutral red (50 pM), induced 80S formation (data not shown). The 'amodiaquin group' included chlorpromazine (20 pM) and the ionophore monensin (1 pM). Fig. 2 shows the temporal evolution of eclipse particle formation in the presence or absence of 20 pM-chlorpromazine at 1 h (a), 2 h (b) and 3 h (c) p.i. Again, 110S formation was specifically inhibited, while 135S and a smaller amount of 80S particles accumulated.
Influence of weak bases on the proteolytic processing of eclipse particles
Compounds from the 'amodiaquin group' specifically inhibited the processing of 135S to 110S particles, which involves an extension of the proteolytic cleavage of the 135S capsid proteins (Everaert et al., 1989) . Since the suppression of l l0S formation probably indicated inhibition of the proteolytic processing of 135S particles, and the formation of the latter particles was not inhibited (Fig. 2) , we compared the peptide composition of 135S particles from both amodiaquin-treated and control cells. Chloroquine-(20 pM) treated cells were included to obtain information on the proteins of the 80S particles.
In these experiments, [~H]valine-labelled virus was used to maximize the labelling of VP 1, the capsid protein most susceptible to proteolytic attack (Everaert et al., 1989) . After 15 rain preincubation with the compounds and addition of [aH]valine-labelled virus, incubation was continued for 1 h or 3 h to maximize the yield of 110S particles. The results are shown in Fig. 3 . At 1 h p.i., mainly 135S particles had been formed in both untreated and amodiaquin-treated cells (Fig. 3 a to  c) and, as expected, the dominant eclipse product was 80S in chloroquine-treated cells (Fig. 3d) . At 3 h p.i., untreated cells contained a substantial amount of 110S material (Fig. 3 b) .
Peak fractions of 80S, 135S and 110S (indicated by squares in Fig. 3a to d) were pooled for polypeptide analysis. The basic pattern of 160S proteins is shown in panel (e). The relative amounts of VP1, VP2 and VP3 were consistent with the valine content. The slight excess of VP4 is possibly due to admixture of 135S which, as expected (Everaert et al., 1989) , had already undergone proteolysis, especially of VP1 (Fig. 3f) . The l l0S particles had lost most of VP1 and all of intact VP2 (Fig.  3g) . The peptide pattern of 135S particles from amodiaquin-treated cells (Fig. 3 h) closely resembled that of native 160S virions (Fig. 3 e) , showing that amodiaquin blocked proteolytic processing. The 80S empty capsids formed under the influence of chloroquine also showed little evidence of proteolytic degradation (Fig. 3 i) . P. Kronenberger, R. Vrijsen and A. Boeyd We conclude that both 20 gM-amodiaquin and 20 pMchloroquine blocked proteolytic processing of intracellular eclipse particles for at least 1 h p.i.
Intracellular transport
The observation that weak bases can halt proteolysis may be explained by their effect on intravesicular pH, by direct inhibition of proteolytic enzymes (Wibo & Poole, 1974) , or by inhibition of intracellular transit to lysosomes. The latter possibility was ruled out for chloroquine up to 50 ~tM, since no difference in the amount of lysosomal virus label could be detected between treated and untreated cells (Kronenberger et al., 1992b) .
We examined the accumulation of 135S partictes in lysosomes under the influence of amodiaquin or monensin. The latter compound has been reported to block intracellular traffic of some ligands and of poliovirus (Wileman et al., 1984; Gromeier & Wetz, 1990) . Transit to lysosomes was monitored using ratezonal Nycodenz gradient centrifugation of cellular homogenates (see Methods). Lysosomes sediment in the middle region (MR) of such gradients, whereas the bulk of plasma membrane-associated virions sediment at the bottom (BR). The top region (TR) contains small vesicular material, as well as free, possibly cytosolic viral particles (Kronenberger et al., 1992a, b) .
After a 15 rain preincubation at 37 °C with 0, 10, 20 or 30 laM-amodiaquin and 1 or 5 pM-monensin, [aH]valinelabelled virus was added. Incubation was for 1 h p.i. The cell suspensions were washed twice, homogenized by shear forces and analysed in Nycodenz gradients. Lysosomes were located by assaying the marker enzyme N-acetyl-fl-glucosaminidase.
The results are shown in Fig. 4 . Control cells (Fig. 4a , tracing a) displayed the expected pattern of virions associated with plasma membrane (BR), with lysosomes (MR) and with the vesicular and cytosolic fraction sedimenting near the top of the gradient (TR). Amodiaquin caused a severe reduction of the MR peak and a lesser reduction in the TR peak, while the BR peak remained constant (Fig. 4a, tracings b to d) . The reduction in MR could not be explained by destruction of lysosomes, as judged from the unchanged distribution of the marker enzyme (Fig. 4a, dashed curves, compare a and c). Monensin did not cause any significant redistribution of viral particles (Fig. 4a , tracings e and f).
Contents of subcellular compartments
Fractions from the TR, MR and BR were pooled as indicated in Fig. 4 (a) , detergent-treated to free the viral particles, and analysed by sucrose gradient centrifugation.
The results for TR are shown in Fig. 4 Only 30 gu-amodiaquin severely reduced the 80S and 135S peaks (tracing d). As will be argued below, this concentration is probably cytotoxic.
The contents of the MR (lysosomal) material is shown in Fig. 4(c) . The MR from control cells (tracing a) contained 160S particles and smaller amounts of 135S and 110S material, as well as a sizeable amount of slowly sedimenting material (fractions 1 to 10). The latter probably represents proteolytic cleavage products, suggesting that not all cleavage products remain associated with the degraded 135S or ll0S particles (as might be inferred from Fig. 3) . Consistent with our earlier findings, the MR contained little 80S material. Amodiaquin drastically reduced the amounts of modified particles and of the slowly sedimenting material (Fig. 4c , tracings b to d), whereas the 160S peak remained constant. The presence of 160S particles in the lysosomes is in apparent contradiction with earlier work (Ofori-Anyinam et al., 1993) , and may represent admixture of TR and BR material, or of non-lysosomal material sedimenting in the MR.
Monensin treatment resulted in suppression of l l0S and inhibited the formation of slowly sedimenting material, whereas the 160S and 135S peaks remained constant (Fig. 4c , tracings e and f).
Consistent with earlier findings, the BR fractions contained 160S particles exclusively (data not shown).
Taken together, the results shown in Fig. 4 establish that proteolytic degradation of subviral particles took place in the lysosomes and that monensin, even at 1 gu, inhibited intralysosomal proteolysis. Inhibition of proteolysis by amodiaquin may be a weak-base effect, but is probably enhanced by inhibition of transit of susceptible 135S particles to the lysosomes. A similar effect was noticed for chlorpromazine at concentrations higher than 20 ~tM (data not shown).
Effect on viral protein synthesis
In the course of the experiment illustrated in Fig. 4 , samples of the cell suspensions were incubated until 3hp.i., and pulse-labelled with [a~S]methionine for 30 rain. The lysates were analysed by SDS-PAGE.
The results are shown in Fig. 5 . When the cells had been treated with 10 ~tM-or 20 gM-amodiaquin (lanes 2 and 3), incorporation was reduced as compared with the untreated control (lane 1), dropping to near zero at 30 ~tM (lane 4). A similar effect was noticed with monensin (lanes 5 and 6). Even though incorporation was reduced the peptide patterns remained typically viral, indicating that host shutoff had proceeded normally in all cases (lanes 4 and 6 upon protracted exposure still displayed faint viral patterns, data not shown).
In conclusion, even though amodiaquin and monensin reduced viral protein synthesis when used at concentra- 
Effect on plaque titre and virus yield
As shown in Table 1 , the plaque titre obtained with 20 gM-chloroquine or 20 gM-amodiaquin (concentrations previously shown to inhibit proteolysis) did not significantly deviate from the controls, and even higher concentrations had hardly any effect. The higher concentrations of most compounds, especially monensin at ~> 5 laM, induced rounding up of cells and reduced uptake of the vital stain, probably reflecting cytotoxicity (marked in Table 1 by an asterisk). The plaques were nevertheless of normal size, indicating that the complete viral cycle was unaffected, even under these stressed conditions.
To ascertain further the lack of interference with infection, we also tested the effect of 20 ~tM-amodiaquin (a concentration that severely reduced lysosomal uptake) on virus production in a single-cycle growth experiment. HeLa suspension cells were preineubated for 15 min at 37 °C with or without amodiaquin, infected at an m.o.i. of 3 p.f.u./cell and sampled every 2 h up to 12 h. The samples were treated with 1% NP40, and the postnuclear supernatants stored at -80 °C until titration. The virus titre increased to 6 x 108 p.f.u./ml (920 p.f.u./ cell) for untreated cells and 2-5x 108p.f.u./ml (380p.f.u./cell) for amodiaquin-treated cells. In both cases, these titres were reached within 8 h, and with similar rates of increase (data not shown).
It is concluded that none of the compounds specifically affected early steps in infection.
Discussion
In agreement with previous findings (Everaert et al., 1989) , the 135S and 110S particles that were formed had an extensively damaged VP1. It might be argued that these proteolytic events are only late-stage events in the eclipse phase and therefore of no relevance. However, proteolysis of 135S particles was detectable as early as 10 rain p.i. (P. Kronenberger, R. Vrijsen and A. Boey~, unpublished results) . Furthermore, the relative amount of the proteolytic product (the 110S particle) is inversely proportional to the input m.o.i. (Everaert et al., 1989) , implying that 110S production does not require a high input m.o.i.
Our results show that proteolytic degradation of 135S particles, as well as the proteolytic processing of 135S to l l0S particles, can be inhibited by acidotropic weak bases and by the proton ionophore monensin, without effect on infection.
The weak bases could be divided into two groups, depending on their effect on eclipse particles. The ' amodiaquin group' (including the ionophore monensin) allowed the formation of intact 135S particles and inhibited 110S formation. Amodiaquin severely reduced intracellular transit to the lysosomes and a similar effect was observed with chlorpromazine (data not shown). Monensin, on the other hand, did not alter intracellular traffic, but inhibited intralysosomal processing to 110S particles. The ~chloroquine group' induced intracellular 80S empty capsids and inhibited formation of both 135S and l l0S particles. We previously found that chloroquine induced 80S particle production in the lysosomes (Kronenberger et al., 1991) ; we now show that these empty capsids remained proteolytically uncleaved. The mechanism of lysosomal 80S induction is still not understood. A mere increase in intravesicular pH is not sufficient, since other powerful pH-perturbing agents, like monensin, do not induce 80S particles. Direct interaction with the viral particles may be involved. For instance, the compounds may bind to viral RNA in a way that causes it to dissociate from the capsid. Interestingly, chloroquine can intercalate and bind the minor groove of double-stranded DNA (Meshnick, 1990) .
Our various interferences with the intracellular eclipse particles failed to halt infection. Moreover, since transit to lysosomes may also be severely reduced without inhibiting infection, we conclude that penetration and/or uncoating must occur from a pre-lysosomal site.
Very recently, P6rez & Carrasco (1993) showed that poliovirus infection was not dependent on low intracellular pH, or at least much less so than the enveloped Semliki Forest and vesicular stomatitis viruses. Our findings are fully compatible with this conclusion. It is indeed difficult to see how two compounds as different as chloroquine and monensin would inhibit proteolysis, unless both cause an increase in vesicular pH. However, one may hypothesize that the upper pH limits for proteolysis and for penetration and/or uncoating are different; the concentrations used in this work may indeed have been sufficient to inhibit the first, but not the latter process. At higher concentrations, the compounds may become cytotoxic, and their effect on infection nonspecific.
A second problem concerns the role of intracellular 135S particles as intermediates in the infectious process. In the absence of inhibitors, most of the intracellular 135S particles do not release their RNA, but are proteolytically degraded to l l0S particles, which still contain RNA. Blocking proteolysis, however, does not enhance the release of RNA from the 135S particles, and no increase is seen in the number of plaques either. It therefore appears that most, if not all, 135S particles are already aborted, whether proteolysis has occurred or not. Does that mean that the 135S eclipse particle is, as such, an irrelevant modification of the viral capsid? Recent findings (Moscufo et at., 1993) emphasizing the existence of an essential function of VP4 (possibly in targeting and/or transport of the viral genome across a membrane), actually support the latter possibility. A non-viable mutant carrying a modified VP4 indeed produced normal amounts of intracellular 135S particles. If these lack VP4 (like those artificially produced in vitro by detergent-solubilized receptor), they cannot supply the essential VP4-associated function and are therefore irrelevant. If, on the other hand, even a minority of 135S particles retain their VP4, these may be important intermediates in infection. Results with non-infective, maturation cleavage-defective rhinovirus mutants (Lee et al., 1993) suggest that the amount of an infecting intermediate may be undetectably small, and that VP4 has a pivotal role in infection.
Since the findings with poliovirus thus stress the role of myristoylated VP4 (Marc et al., 1990; Moscufo et al., 1993) , it will be of interest to find out whether the intact intracellular 135S particles we report in this paper still contain myristoylated VP4.
